Clinical Trials Sponsored by Axel Brandes

Total 1212 results

Cephalon

Completed

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Diabetic Neuropathies | Osteoarthritis | Low Back Pain | Migraine

United States
Cephalon

Completed

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Cephalon

Completed

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

ADHD

United States
Cephalon

Completed

Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD

Excessive Sleepiness | Shift Work Sleep Disorder
Cephalon

Completed

Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bipolar I Depression

United States, Bulgaria, Hungary, Romania
Cephalon

Completed

Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits

Schizophrenia

United States
Cephalon

Completed

Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome

Obstructive Sleep Apnea | Sleep Hypopnea
Cephalon

Completed

Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)

Obstructive Sleep Apnea | Hypopnea
Cephalon

Completed

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Chronic Shift Work Sleep Disorder

United States
Cephalon

Completed

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma

Solid Tumors or Mantle Cell Lymphoma

Belgium, France
Cephalon

Terminated

Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain

Pain | Chronic Pain | Breakthrough Pain

United States
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Schizophrenia

United States
Cephalon

Completed

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Excessive Sleepiness

United States
Cephalon

Terminated

Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

France, Germany, Poland, Sweden, United Kingdom
Cephalon

Completed

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

Chronic Pain

United States
Cephalon

Completed

Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy

Malignancy

Netherlands
Grande International Hospital, Nepal

Completed

Initial Experience of Transabdominal Fetal Reduction in Nepal

In Vitro Fertilization

Nepal
Lisbet Brandi

Unknown

Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease (PoCKET)

Autosomal Dominant Polycystic Kidney

Denmark
Barnes Retina Institute
Allergan

Completed

Anatomic Outcomes Following Ozurdex Injections

Retinal Vein Occlusions

United States
Horsens Hospital
Randers Regional Hospital

Completed

3 Fixation Devices in Laparoscopic Ventral Herniotomy (FS)

Ventral Hernia

Denmark
Shandong Branden Med.Device Co.,Ltd
Hainan Cancer Hospital

Not yet recruiting

The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications (PICC)

Infections | Cancer | Phlebitis | Thrombus
Cephalon

Completed

Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

General Anxiety Disorder

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Terminated

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Stable Renal Transplant Recipients
Cephalon

Terminated

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Fatigue | Chemotherapy Side Effects

United States
Cephalon

Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Polycythemia Vera | Essential Thrombocytosis

United States
Cephalon

Completed

Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, Canada
Cephalon

Completed

Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.

Anxiety Disorders

United States, Canada
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Chronic Neuropathic Pain

United States
Cephalon

Completed

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Cephalon

Completed

Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab

Non-Hodgkin's Lymphoma

United States, Canada, Puerto Rico
Cephalon

Completed

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma

Australia, Canada, United States
Cephalon

Completed

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

Excessive Sleepiness

United States
Cephalon

Completed

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Narcolepsy | Shift-Work Sleep Disorder

United States, Russian Federation
Cephalon

Completed

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Breakthrough Pain
Cephalon

Completed

A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users

Drug Abuse

United States, Canada
Cephalon

Completed

Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma (NHL)

United States, Belgium, Israel
Cephalon

Completed

Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

ADHD | Attention Deficit Hyperactivity Disorder

United States
Cephalon

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Leukemia, Myeloid
Cephalon

Withdrawn

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer
Cephalon

Terminated

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Canada
Cephalon

Completed

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

ADHD | Attention Deficit/Hyperactivity Disorder

United States
Cephalon

Completed

Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer

Cancer
Cephalon

Completed

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

Chronic Pain

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Covance

Terminated

A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

Healthy

United States
The Hillshire Brands Company
Biofortis Clinical Research, Inc.

Unknown

Effects of a Variety of Meals on Satiety

Focus of the Study is Satiety

United States
Cephalon, Inc.

Completed

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

Breast Cancer

Austria, Belgium, France, Germany, Italy, Spain
Teva Branded Pharmaceutical Products R&D, Inc.
FHI 360

Completed

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Pregnancy | Contraception

United States
Cephalon, Inc.

Terminated

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
NCGS, Inc.

Completed

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Episodic Migraine Headache

United States

3

Subscribe